Results 51 to 60 of about 768,553 (208)

HPV Vaccine Promotion: The church as an agent of change.

Social Science & Medicine (1967), 2020
Vaccination to prevent human papillomavirus (HPV) infections and associated cancers has been recommended for use in the US since 2006; however, vaccine uptake remains suboptimal.
Ariana Y Lahijani, Adrian R. King, M. Gullatte, M. Hennink, R. Bednarczyk   +4 more
semanticscholar   +1 more source

Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies

Vaccine, 2018
The Costa Rica Vaccine Trial (CVT), a phase III randomized clinical trial, provided the initial data that one dose of the HPV vaccine could provide durable protection against HPV infection.
A. Kreimer, R. Herrero, J. Sampson, C. Porras, D. Lowy, J. Schiller, M. Schiffman, A. Rodriguez, S. Chanock, Silvia E. Jiménez, John Schussler, M. Gail, Mahboobeh Safaeian, T. Kemp, Bernal Cortés, L. Pinto, A. Hildesheim, Paula González   +17 more
semanticscholar   +1 more source

Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: the CVT Trial.

Journal of the National Cancer Institute, 2020
BACKGROUND The Costa Rica HPV Vaccine Trial (CVT) has documented cross-protection of the bivalent HPV vaccine against HPV31/33/45 up to seven years after vaccination, even with one dose of the vaccine.
Sabrina H. Tsang, J. Sampson, John Schussler, C. Porras, Sarah Wagner, J. Boland, Bernal Cortés, D. Lowy, J. Schiller, M. Schiffman, T. Kemp, A. Rodriguez, W. Quint, M. Gail, L. Pinto, Paula González, A. Hildesheim, A. Kreimer, R. Herrero   +18 more
semanticscholar   +1 more source

Updates on HPV Vaccination

Diagnostics, 2023
Cervical cancer still poses a significant global challenge. Developed countries have mitigated this challenge by the introduction of structured screening programmes and, more recently, the HPV vaccine. Countries that have successfully introduced national HPV vaccination programmes are on course for cervical cancer elimination in a few decades.
Ojone Illah, Adeola Olaitan
openaire   +3 more sources

Effectiveness of HPV vaccine as part of national immunization program for preventing HPV infection in Thai schoolgirls after seven years post-vaccination

Human Vaccines & Immunotherapeutics
Thailand introduced a two-dose regimen of bivalent HPV vaccines for Grade 5 schoolgirls, approximately 11 years old, initially piloted in Ayutthaya province in 2014, and nationwide under the National Immunization Program (NIP) in 2017.
Pornjarim Nilyanimit, Preeyaporn Vichaiwattana, Ratchadawan Aeemchinda, Wichan Bhunyakitikorn, Thanawadee Thantithaveewat, Sunanta Seetho, Darunee Phosri, Naiyana Netthip, Nungruthai Suntronwong, Nasamon Wanlapakorn, Yong Poovorawan   +10 more
doaj   +1 more source

Human papillomavirus vaccine administration behaviors and influences among Arizona pharmacists and pharmacy interns

Human Vaccines & Immunotherapeutics, 2021
This study assessed 27 Arizona community pharmacists’ and pharmacy interns’ human papillomavirus (HPV) vaccine administration behaviors and influences.
Alexis Koskan, Maricarmen Vizcaino, Stephanie A. Brennhofer, Chong D. Lee, Anthony J. Roberto   +4 more
doaj   +1 more source

Predictor of HPV Vaccination Uptake among Foreign-Born College Students in the U.S.: An Exploration of the Role of Acculturation and the Health Belief Model

Vaccines, 2023
Objective: to measure the HPV vaccination rate and knowledge about HPV and its vaccine among foreign-born college students; additionally, to measure the effect of acculturation and HBM constructs on the HPV vaccination behavior among foreign-born college
Fahad T. Alsulami, Jesus Sanchez, Silvia E. Rabionet, Ioana Popovici, Mohamed A. Baraka   +4 more
doaj   +1 more source

Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related disease in females and males

Cochrane Database of Systematic Reviews, 2019
Background Uptake of human papillomavirus (HPV) vaccine remains low in many countries, although the bivalent and quadrivalent HPV vaccines given as a three‐dose schedule are effective in the prevention of precancerous lesions of the cervix in women ...
H. Bergman, B. Buckley, Gemma Villanueva, J. Petkovic, C. Garritty, V. Lutje, A. X. Riveros-Balta, N. Low, N. Henschke   +8 more
semanticscholar   +1 more source

The impact of vaccine access difficulties on HPV vaccine intention and uptake among female university students in China

International Journal for Equity in Health
Background Ensuring vaccine access is a prerequisite for promoting human papilloma virus (HPV) vaccination. Although HPV vaccination efforts in China have primarily focused on young females, little research has examined the difficulties they face in ...
Weiyi Wang
doaj   +1 more source

PREDITORS AND ACCEPTABILITY OF HUMAN PAPILLOMA VIRUS VACCINE UPTAKE AMONG SENIOR SECONDARY SCHOOL STUDENTS IN ILE-IFE

Sanamed, 2019
Introduction: Cervical cancer is the second most common cancer in women worldwide and in Nigeria. Human papilloma virus (HPV), has been implicated as the causative agent of cervical cancer. The fact that HPV vaccination can prevent the occurrence of this
Fehintola O Funmito, Fehintola O Akintunde, Ogundele A Olorunfemi, Adegbenro A Caleb, Olowookere A Samuel, Afolabi T Olusegun   +5 more
doaj   +1 more source